Article Text
Abstract
Background Adult asthma is phenotypically heterogeneous with unclear aetiology. We aimed to evaluate the potential contribution of environmental exposure and its ensuing response to asthma and its heterogeneity.
Methods Environmental risk was evaluated by assessing the records of National Health Insurance Research Database (NHIRD) and residence-based air pollution (particulate matter with diameter less than 2.5 micrometers (PM2.5) and PM2.5-bound polycyclic aromatic hydrocarbons (PAHs)), integrating biomonitoring analysis of environmental pollutants, inflammatory markers and sphingolipid metabolites in case–control populations with mass spectrometry and ELISA. Phenotypic clustering was evaluated by t-distributed stochastic neighbor embedding (t-SNE) integrating 18 clinical and demographic variables.
Findings In the NHIRD dataset, modest increase in the relative risk with time-lag effect for emergency (N=209 837) and outpatient visits (N=638 538) was observed with increasing levels of PM2.5 and PAHs. Biomonitoring analysis revealed a panel of metals and organic pollutants, particularly metal Ni and PAH, posing a significant risk for current asthma (ORs=1.28–3.48) and its severity, correlating with the level of oxidative stress markers, notably Nε-(hexanoyl)-lysine (r=0.108–0.311, p<0.05), but not with the accumulated levels of PM2.5 exposure. Further, levels of circulating sphingosine-1-phosphate and ceramide-1-phosphate were found to discriminate asthma (p<0.001 and p<0.05, respectively), correlating with the levels of PAH (r=0.196, p<0.01) and metal exposure (r=0.202–0.323, p<0.05), respectively, and both correlating with circulating inflammatory markers (r=0.186–0.427, p<0.01). Analysis of six phenotypic clusters and those cases with comorbid type 2 diabetes mellitus (T2DM) revealed cluster-selective environmental risks and biosignatures.
Interpretation These results suggest the potential contribution of environmental factors from multiple sources, their ensuing oxidative stress and sphingolipid remodeling to adult asthma and its phenotypic heterogeneity.
- Asthma
Data availability statement
All data relevant to the study are included in the article or uploaded as online supplemental information.
Statistics from Altmetric.com
Data availability statement
All data relevant to the study are included in the article or uploaded as online supplemental information.
Footnotes
C-CWu and C-CWa contributed equally.
Contributors C-CWu: conceptualisation, methodology, investigation, resources. C-CWa: conceptualisation, methodology, investigation, resources. W-YC: methodology, investigation, writing-original draft, writing-review and editing. C-CS: conceptualisation, resources. Y-HY: software, formal analysis, investigation, resources, supervision, writing-review and editing. M-YC: software, formal analysis, investigation. R-SL: methodology, investigation, resources. S-YL: methodology, investigation, resources. C-CL: methodology, investigation, resources. Y-FW: methodology, investigation, resources. C-HL: methodology, investigation, resources. S-HL: methodology, investigation, resources. J-YH: methodology, investigation, resources. W-CH: methodology, investigation, resources. C-CT: methodology, investigation, resources. Y-FL: methodology, investigation, resources. M-HC: methodology, investigation, resources. H-CC: methodology, investigation, resources. C-JY: methodology, investigation, resources. S-CH: methodology, investigation, resources. C-HS: software, formal analysis, investigation, writing-review and editing. C-JW: methodology, investigation, resources. H-JL: methodology, investigation, resources. H-LC: investigation, writing-review and editing. Y-TH: investigation, writing-review and editing. C-HH: conceptualisation, methodology, resources, writing-review and editing, project administration. CLL: conceptualisation, methodology, validation, resources, writing-review and editing, supervision. M-SH: conceptualisation, methodology, validation, resources, writing-review and editing, supervision. S-KH: conceptualisation, methodology, validation, formal analysis, investigation, resources, writing-original draft, writing-review and editing, supervision, project administration, funding acquisition, guarantor.
Funding This work was supported, in part, by grants from National Health Research Institutes, Taiwan (EOPP10-014, EOSP07-014 and NHRI-102A1-PDCO-03010201) and Ministry of Health and Welfare, Taiwan (EODOH01), National Science Council (NSC 102-2314-B-037-052), Ministry of Science and Technology (MOST 103-2320-B-110–001) and Academia Sinica (BM-102021170), Taiwan.
Disclaimer These funding agencies had no role in study design, the collection and analysis of data, the decision to publish or the preparation of the manuscript.
Competing interests None declared.
Provenance and peer review Not commissioned; externally peer reviewed.
Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.